- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +87 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Stanford University Hospitals and Clinics Stanford, California, United States
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
- Universitaet Leipzig Leipzig, Germany
Clinical trial condition
Refractory Multiple Myeloma
Explore clinical trials studying Refractory Multiple Myeloma. Study availability and eligibility vary by location and protocol.
153 public trials
23 recruiting studies
Refractory Multiple Myeloma trial results
NCT00856388
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, +179 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT01529827
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +179 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT00005799
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, +105 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Stanford University Hospitals and Clinics Stanford, California, United States
- University of Colorado Denver, Colorado, United States
- Baylor University Medical Center Dallas, Texas, United States
Completed
Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma
NCT01447914
- Conditions
- Amyloidosis, Anemia, Blood Protein Disorders, +38 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00002787
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01273766
- Conditions
- Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +206 more
- Locations
-
- Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
NCT01053494
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Amyloidosis, +170 more
- Locations
-
- Wake Forest University Health Sciences Winston-Salem, North Carolina, United States
NCT01129193
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +118 more
- Locations
-
- The Ohio State University James Cancer Hospital Columbus, Ohio, United States
Completed
Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma
NCT01083602
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +19 more
- Locations
-
- University of California at Los Angeles Los Angeles, California, United States
- Stanford University Medical Center Division of Hematology Stanford, California, United States
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
- Emory University School of Medicine/Winship Cancer Institute Dept. of Winship Cancer Inst. Atlanta, Georgia, United States